Education:
Professional Experience:
Research Interests:My research interests have revolved around improving clinical outcomes through the optimal use of drugs in the compromised patient. Data describing the use of drugs in critically ill patients is lacking and poorly described due to the nature of the changing patient. Clinicians are forced to use toxic or expensive drugs with very little guidance. Therefore, applying pharmacokinetic dosing of these drugs in sick patients has been useful in maintaining patient safety while resolving disease processes. As my career evolved, I became interested in teaching the next generation of clinicians how to think through complicated situations and to make the appropriate drug choice based on known or presumed information. As the Executive Associate Dean, my research interests will evolve into studying the best teaching methods for guiding critical thought process and creating techniques to track student progress.
Selected Publications:Pruett T, McGory R. Hepatitis B Immune Globulin: the US Experience. Clinical Transplantation, Vol. 14, supp 2, 2000, 7. Terrault N, Zhou S, McGory R, Pruett T, Lake J, Roberts J, Ascher N, Wright T. Incidence and Clinical Consequences of Surface and Polymerase Gene Mutations in Liver Transplant Recipients on Hepatitis B Immunoglobulin. Hepatology, Vol. 28, 1998, 555. Sawyer R, McGory R, Gaffey M, Shephard B, McCullough C, Houlgrave C, Ryan T, Kuhns M, McNamara A, Caldwell S, Abdulkareem A, Pruett T. Improved Clinical Outcomes with Liver Transplantation for Hepatitis B Induced Chronic Liver Failure Using Passive Immunization. Annals of Surgery, Vol. 227 #6, 1998, 841. Ishitani M, McGory R, Dickson R, Caldwell S, Bickston S, McCullough C, Pruett T, Terrault N, Roberts J, Ascher N, Wright T, Lake J. Retransplantation of Patients with Severe Posttransplant Hepatitis B in the First Allograft. Transplantation, Vol. 64, #3, 1997, 410. Al-Hemsi B, McGory R, Shephard B, Ishitani M, Stevenson W, McCullough C, Pruett T. Liver Transplantation for Hepatitis B Cirrhosis: Clinical Sequela of Passive Immunization. Clin Transplantation, Vol. 10, 1996, 668. Ishitani M, McGory R, Dickson R, Caldwell S, Bickston S, McCullough C, Pruett T. Successful Retransplantation For Recurrent Posttransplant Hepatitis B Virus Infection In The Primary Allograft. Trans. Proc., Vol. 28, #3, 1996, 1714. McGory R, Ishitani M, Oliveira W, Stevenson W, McCullough C, Dickson R, Caldwell S, Pruett T. Improved Outcome of Orthotopic Liver Transplantation for Chronic Hepatitis B Cirrhosis With Aggressive Passive Immunization. Transplantation, Vol. 61, #9, 1996, 1358. Schwenzer K, Vega H, McGory R. Intravenous Ketorolac for Patients in Intensive Care Units. Anesth Review, Vol. 21., #4, 1994, 125. Kiyasu P, Ishitani M, McGory R, Gaffey M, Dickson R, Caldwell S, Stevenson W, Pruett T. Prevention of Hepatitis B "Rerecurrence" after a Second Liver Transplant - The Role of Maintenance Polyclonal HBIG Therapy. Transplantation, 1994, 58, 954. Matzke G, McGory R, Halverston C, Keane W. Vancomycin Pharmacokinetics in Patients with Various Degrees of Renal Function; A Nomogram for Dosage. Antimicrobial Agents and Chemotherapy, 1984; 25, 433. McGory R, Matzke G. Evaluation of a Single-Point Method for Predicting Theophylline Dosage. Clinical Pharmacy. 1982; 1, 441.
|
